GOLDENBERG GARY sold 29.0% of their position (28.70K shares) of VERRICA PHARMACEUTICALS INC. on the open market
Open‑market sale worth $138.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/25/2023ACC: 0001209191-23-043304
Director
Since Jun 2019
+46.30K
Net shares
Net buyer
$138.6K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
75K acquired · 28.70K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+75K
Price / share
—
Trade value
—
% of position
315.0%
7/21/2023
23.81K→98.81K
Common Stock
Direct
Shares
−28.70K
Price / share
$4.83
Trade value
$138.62K
% of position
29.0%
7/24/2023
98.81K→70.11K
Total
Net shares
+46.30K
Net value
-$138.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/21/2023 | A · Award | +75K | — | — | 315.0% | 23.81K | 98.81K |
| Common Stock Direct | 7/24/2023 | S · Sale | −28.70K | $4.83 | $138.62K | 29.0% | 98.81K | 70.11K |
| Total | +46.30K | -$138.62K | ||||||
Derivative Transactions0
No derivative transactions reported